| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |